aTyr Pharma
LIFE
$1.90
Share price
2.70%
Change (1 day)
-9.95%
Change (1 year)
Categories
aTyr Pharma (LIFE) - Total debt
Total debt on the balance sheet as of March 2024 : $14.12 M
According to aTyr Pharma's latest financial reports the company's total debt is $14.12 M. A company’s total debt is the sum of all current and non-current debts.
aTyr Pharma - Total debt on balance sheet (from 2014 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $15.09 M | 30.87% |
| 2022-12-31 | $11.53 M | 737.01% |
| 2021-12-31 | $1.37 M | -38.45% |
| 2020-12-31 | $2.23 M | -80.91% |
| 2019-12-31 | $11.73 M | -26.82% |
| 2018-12-31 | $16.03 M | -18.76% |
| 2017-12-31 | $19.73 M | 106.89% |
| 2016-12-31 | $9.53 M | 85.47% |
| 2015-12-31 | $5.14 M | -49.96% |
| 2014-12-31 | $10.27 M | 49.23% |
| 2013-12-31 | $6.88 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Vertex Pharmaceuticals VRTX | $0.72 B | 5,006.19% | 🇺🇸 USA |
 Veracyte VCYT | $14.04 M | -0.61% | 🇺🇸 USA |